What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary scientific interests are in Pharmacology, Biochemistry, Organic anion transporter 1, Efflux and Transporter.
His Pharmacology research includes elements of Internal medicine, Kidney, Abcg2 and Multidrug resistance-associated protein 2.
His Organic Anion Transport Protein 1 and Glucuronide study in the realm of Biochemistry connects with subjects such as Sitosterolemia.
The Organic anion transporter 1 study combines topics in areas such as Probenecid, Virus, Viral replication and Organic cation transport proteins.
His work deals with themes such as P-glycoprotein, Blood–brain barrier and Intracellular, which intersect with Efflux.
As part of one scientific family, Hiroyuki Kusuhara deals mainly with the area of Transporter, narrowing it down to issues related to the Drug, and often Biophysics and Cerebrospinal fluid.
His most cited work include:
- Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. (471 citations)
- Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain (450 citations)
- Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. (362 citations)
What are the main themes of his work throughout his whole career to date?
Hiroyuki Kusuhara mostly deals with Pharmacology, Transporter, Pharmacokinetics, Internal medicine and Organic anion transporter 1.
His research in Pharmacology intersects with topics in Efflux, Kidney, Abcg2 and In vivo.
His studies deal with areas such as Cell biology and Choroid plexus as well as Transporter.
His work on Physiologically based pharmacokinetic modelling as part of general Pharmacokinetics research is frequently linked to Crossover study, bridging the gap between disciplines.
Hiroyuki Kusuhara usually deals with Internal medicine and limits it to topics linked to Endocrinology and Knockout mouse.
Organic anion transporter 1 is the subject of his research, which falls under Biochemistry.
He most often published in these fields:
- Pharmacology (47.96%)
- Transporter (23.20%)
- Pharmacokinetics (21.94%)
What were the highlights of his more recent work (between 2017-2021)?
- Pharmacology (47.96%)
- Drug (10.03%)
- Pharmacokinetics (21.94%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pharmacology, Drug, Pharmacokinetics, Transporter and In vivo.
His work on Pitavastatin as part of general Pharmacology research is often related to Crossover study, thus linking different fields of science.
His Pharmacokinetics research includes elements of Oral administration, Distribution and Multidrug resistance-associated protein 2.
The concepts of his Transporter study are interwoven with issues in Phenotype, Efflux, In vitro and Cell biology.
His Efflux study integrates concerns from other disciplines, such as Abcg2, Ussing chamber, Peptide transporter 1, Molecular biology and Kidney.
His In vivo study combines topics in areas such as Biomarker, Local field potential and Premovement neuronal activity.
Between 2017 and 2021, his most popular works were:
- Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium (49 citations)
- Endogenous Probes for Drug Transporters: Balancing Vision With Reality. (49 citations)
- Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers. (35 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Hiroyuki Kusuhara focuses on Pharmacology, Transporter, Pharmacokinetics, Endogeny and In vivo.
His Pharmacology research integrates issues from Organic anion transporter 1, Organic anion-transporting polypeptide, Biomarker and Rifampicin.
His Organic anion transporter 1 research incorporates elements of Cimetidine and Renal function.
He combines subjects such as Inflammation, Lipopolysaccharide, Drug and Cell biology with his study of Transporter.
His Pharmacokinetics study deals with Distribution intersecting with Excretion, Drug development, New chemical entity and Urine.
His In vivo research is multidisciplinary, incorporating elements of Messenger RNA, Gene knockin, Sultopride and Ligand.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
